"New Science" is Leading Growth While Changing the Market Dynamics of the Biopharma Industry, According to New Research from Accenture

NEW YORK: April 4, 2019 – The adoption of a unique combination of the best in science and health technology such as genomics, biomarkers and companion technologies are expected to be the biopharmaceutical industry’s new growth machine, according to new research from Accenture (NYSE: ACN).

from News | Accenture Newsroom https://ift.tt/2IikJx1




Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

UK to Receive Egyptian LNG Cargo

HANA Housekeeping using HANACleaner